External validation and comparison of six prognostic models in a prospective cohort of HBV-ACLF in China.

UNLABELLED  Background. Acute-on-chronic liver failure has high mortality. Currently, robust models for predicting the outcome of hepatitis B virus (HBV)-associated ACLF are lacking. AIM To assess and compare the performance of six prevalent models for short- and longterm prognosis in patients with HBV-ACLF. MATERIAL AND METHODS The model for end-stage liver disease (MELD), MELD sodium (MELD-Na), MELD to sodium ratio (MESO), integrated MELD, Child-Turcotte-Pugh (CTP), and modified CTP (mCTP) were validated in a prospective cohort of 232 HBV-ACLF patients. The six models were evaluated by determining discrimination, calibration and overall performance at 3 months and 5 years. RESULTS According to the Hosmer-Lemeshow tests and calibration plots, all models could adequately describe the data except CTP at 3 months. Discrimination analysis showed that the iMELD score had the highest AUC of 0.76 with sensitivity of 62.6% and specificity of 80.2% for an optimal cut-off value of 52 at 3 months. It also had the highest AUC of 0.80 with sensitivity of 89.9% and specificity of 48.2% for an optimal cut-off value of 43 at 5 years. The overall performance of iMELD, assessed with Nagelkerke's R2 and the Brier score, was also the best among the six models. CONCLUSION Integrated MELD may be the best model to predict short- and long-term prognosis in patients with HBV-ACLF.

[1]  M. Zheng,et al.  Establishment and Validation of ALPH-Q Score to Predict Mortality Risk in Patients With Acute-on-Chronic Hepatitis B Liver Failure , 2015, Medicine.

[2]  A. Rosenkranz,et al.  Hyponatremia to be an excellent predictor of outcome in patients with advanced cirrhosis. , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[3]  N. Nagelkerke,et al.  A note on a general definition of the coefficient of determination , 1991 .

[4]  R. Pugh,et al.  Transection of the oesophagus for bleeding oesophageal varices , 1973, The British journal of surgery.

[5]  Chen Li,et al.  Combining Serum Cystatin C with Total Bilirubin Improves Short-Term Mortality Prediction in Patients with HBV-Related Acute-On-Chronic Liver Failure , 2015, PloS one.

[6]  Y. Chawla,et al.  Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014 , 2009, Hepatology International.

[7]  R. Quinn,et al.  Gender, renal function, and outcomes on the liver transplant waiting list: assessment of revised MELD including estimated glomerular filtration rate. , 2011, Journal of hepatology.

[8]  R. Moreau,et al.  Acute-on-chronic liver failure: A new syndrome that will re-classify cirrhosis. , 2015, Journal of hepatology.

[9]  S. Sarin,et al.  Acute-on-chronic Liver Failure , 2016, Current Gastroenterology Reports.

[10]  Yihua Wu,et al.  A novel integrated Model for End‐Stage Liver Disease model predicts short‐term prognosis of hepatitis B virus‐related acute‐on‐chronic liver failure patients , 2015, Hepatology research : the official journal of the Japan Society of Hepatology.

[11]  Jianpin Liu,et al.  Artificial and bioartificial support systems for liver failure. , 2004, The Cochrane database of systematic reviews.

[12]  P. Kamath,et al.  A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts , 2000, Hepatology.

[13]  L. Risch,et al.  Cystatin C is a strong predictor of survival in patients with cirrhosis: is a cystatin C‐based MELD better? , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[14]  P. Kamath,et al.  Acute-on-chronic liver failure: concept, natural history, and prognosis , 2011, Current opinion in critical care.

[15]  M. Zheng,et al.  Nucleoside Analogue Can Improve the Long-Term Prognosis of Patients with Hepatitis B Virus Infection-Associated Acute on Chronic Liver Failure , 2010, Digestive Diseases and Sciences.

[16]  A. Burroughs,et al.  Acute-on-chronic liver failure , 2015, The Lancet.

[17]  Yeong-Seok Im,et al.  Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List , 2009 .

[18]  V. Arroyo,et al.  MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation , 2007, Gut.

[19]  Yi Shen,et al.  Artificial Liver Support System Improves Short- and Long-Term Outcomes of Patients With HBV-Associated Acute-on-Chronic Liver Failure , 2014, Medicine.

[20]  E. Mascha,et al.  Pre-transplant MELD and sodium MELD scores are poor predictors of graft failure and mortality after liver transplantation , 2011, Hepatology international.

[21]  Jürgen Wasem,et al.  Cost-effectiveness of the artificial liver support system MARS in patients with acute-on-chronic liver failure , 2010, European journal of gastroenterology & hepatology.

[22]  David W. Hosmer,et al.  Applied Logistic Regression , 1991 .

[23]  A. Burroughs,et al.  Selection of patients for liver transplantation and allocation of donated livers in the UK , 2007, Gut.

[24]  C. Sima,et al.  Re-weighting the model for end-stage liver disease score components. , 2008, Gastroenterology.

[25]  G. Zang,et al.  Prognostic performance of a series of model for end-stage liver disease and respective Δ scores in patients with hepatitis B acute-on-chronic liver failure , 2014, Molecular medicine reports.

[26]  T. Therneau,et al.  Evidence-based incorporation of serum sodium concentration into MELD. , 2006, Gastroenterology.

[27]  Xiaowei Xu,et al.  A single-center experience of non-bioartificial liver support systems among Chinese patients with liver failure , 2014, The International journal of artificial organs.

[28]  N. Obuchowski,et al.  Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures , 2010, Epidemiology.

[29]  Liver Failure,et al.  Diagnostic and treatment guidelines for liver failure , 2006 .

[30]  M. Yuen,et al.  Acute‐on‐chronic liver failure in chronic hepatitis B , 2012, Journal of gastroenterology and hepatology.

[31]  S. Kim,et al.  Predictors of mortality in cirrhotic patients undergoing extrahepatic surgery: comparison of Child–Turcotte–Pugh and model for end‐stage liver disease‐based indices , 2014, ANZ journal of surgery.

[32]  F. Chang,et al.  Proposal of a modified Child‐Turcotte‐Pugh scoring system and comparison with the model for end‐stage liver disease for outcome prediction in patients with cirrhosis , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[33]  M. Ronsoni,et al.  Single‐centre validation of the EASL‐CLIF Consortium definition of acute‐on‐chronic liver failure and CLIF‐SOFA for prediction of mortality in cirrhosis , 2015, Liver international : official journal of the International Association for the Study of the Liver.

[34]  M. Biselli,et al.  Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: Which is the winner? , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[35]  J. Bosch,et al.  An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[36]  J. Perkins,et al.  D‐MELD, a Simple Predictor of Post Liver Transplant Mortality for Optimization of Donor/Recipient Matching , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[37]  S. Fuchs,et al.  MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil , 2012, Clinical transplantation.

[38]  D. Shawcross,et al.  Meld score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation , 2007 .

[39]  J. Heimbach,et al.  Liver and Intestine Transplantation in the United States 1998–2007 , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[40]  Trichostatin A Protects Against Experimental Acute-on-Chronic Liver Failure in Rats Through Regulating the Acetylation of Nuclear Factor-κB , 2015, Inflammation.

[41]  Evangelos Cholongitas,et al.  MELD is not enough--enough of MELD? , 2005, Journal of hepatology.

[42]  Yoshiyuki Suzuki,et al.  Lamivudine monotherapy for spontaneous severe acute exacerbation of chronic hepatitis B , 2004, Journal of gastroenterology and hepatology.

[43]  Shou-Dong Lee,et al.  Model for end‐stage liver disease score to serum sodium ratio index as a prognostic predictor and its correlation with portal pressure in patients with liver cirrhosis , 2007, Liver international : official journal of the International Association for the Study of the Liver.